Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


3rd Patient Adherence and Advocacy Summit

25 Feb 2013 - 26 Feb 2013 - PA, USA



Bookmark and Share


The 2nd Patience Adherence Summit was a huge success with overwhelmingly positive feedback and comments from the audience evals. Our vision for the 3rd Patience Adherence and Advocacy Summit is to incorporate more of a patient-centric, patient-empowered focus as well as patient advocacy. The event will be very engaging and participant-oriented. Real-world scenarios and case studies will be featured and the audience will be fully engaged in learning and discovering innovative ideas on how to address and aid in the remedy of this devestaing industry-wide problem.

KEY LEARNING OBJECTIVES

Gain insightful new ideas to help Pharma understand why working with advocacy organizations not only makes good business sense, but how a patient can benefit from this collaboration as well

Understand how significant mobile technologies and digital platforms play in the rising adherence rates and how to incorporate these tools into your marketing plans

Leverage opportunities to work with government and non-profit agencies to better facilitate patient access to treatment

Recognize that extrinsic motivators are only short-lived and intrinsic motivators must be targeted for long-term behavior change

Determine the pharma-specific perceptions and rules that impact how industry works with advocacy groups

Incorporate your adherence messages with push and pull marketing



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!